Cited 0 times in
Cited 0 times in
Preliminary results from a phase I study using the bispecific, human epidermal growth factor 2 (HER2)-targeting antibody-drug conjugate (ADC) zanidatamab zovodotin (ZW49) in solid cancers
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2023-06-02T01:07:10Z | - |
dc.date.available | 2023-06-02T01:07:10Z | - |
dc.date.issued | 2022-09 | - |
dc.identifier.issn | 0923-7534 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/194663 | - |
dc.description.statementOfResponsibility | restriction | - |
dc.language | English | - |
dc.publisher | Oxford University Press | - |
dc.relation.isPartOf | ANNALS OF ONCOLOGY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.title | Preliminary results from a phase I study using the bispecific, human epidermal growth factor 2 (HER2)-targeting antibody-drug conjugate (ADC) zanidatamab zovodotin (ZW49) in solid cancers | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
dc.contributor.googleauthor | K. Jhaveri | - |
dc.contributor.googleauthor | H. Han | - |
dc.contributor.googleauthor | E. Dotan | - |
dc.contributor.googleauthor | D-Y. Oh | - |
dc.contributor.googleauthor | C. Ferrario | - |
dc.contributor.googleauthor | A. Tolcher | - |
dc.contributor.googleauthor | K-W. Lee | - |
dc.contributor.googleauthor | C-Y. Liao | - |
dc.contributor.googleauthor | Y-K. Kang | - |
dc.contributor.googleauthor | Y.H. Kim | - |
dc.contributor.googleauthor | E. Hamilton | - |
dc.contributor.googleauthor | A. Spira | - |
dc.contributor.googleauthor | N. Patel | - |
dc.contributor.googleauthor | C. Karapetis | - |
dc.contributor.googleauthor | S.Y. Rha | - |
dc.contributor.googleauthor | L. Boyken | - |
dc.contributor.googleauthor | J. Woolery | - |
dc.contributor.googleauthor | P. Bedard | - |
dc.identifier.doi | 10.1016/j.annonc.2022.07.589 | - |
dc.relation.journalcode | J00171 | - |
dc.identifier.eissn | 1569-8041 | - |
dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S0923753422024401 | - |
dc.citation.volume | 33 | - |
dc.citation.number | Supplement 7 | - |
dc.citation.startPage | S749 | - |
dc.citation.endPage | S750 | - |
dc.identifier.bibliographicCitation | ANNALS OF ONCOLOGY, Vol.33(Supplement 7) : S749-S750, 2022-09 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.